4
Changes in Ownership
Summit Therapeutics Inc. Filed Acc 0001599298-23-000004
Options or other derivatives
- Director acquired 79,400 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Clark Kenneth A · Director
Table II: Derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-03 | Grant or award : show line 1 in the form Stock Option (right to buy) | +35,000 | 35,000 | D | ||
| 2023-01-03 | Grant or award : show line 2 in the form Stock Option (right to buy) | +44,400 | $1.67 | $74,148 | 79,400 | D |
Loading xslF345X03/wf-form4_167295314354996.xml…